Correlation Between AIM ImmunoTech and Target Healthcare

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AIM ImmunoTech and Target Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AIM ImmunoTech and Target Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AIM ImmunoTech and Target Healthcare REIT, you can compare the effects of market volatilities on AIM ImmunoTech and Target Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AIM ImmunoTech with a short position of Target Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of AIM ImmunoTech and Target Healthcare.

Diversification Opportunities for AIM ImmunoTech and Target Healthcare

-0.04
  Correlation Coefficient

Good diversification

The 3 months correlation between AIM and Target is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding AIM ImmunoTech and Target Healthcare REIT in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Target Healthcare REIT and AIM ImmunoTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AIM ImmunoTech are associated (or correlated) with Target Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Target Healthcare REIT has no effect on the direction of AIM ImmunoTech i.e., AIM ImmunoTech and Target Healthcare go up and down completely randomly.

Pair Corralation between AIM ImmunoTech and Target Healthcare

Assuming the 90 days trading horizon AIM ImmunoTech is expected to under-perform the Target Healthcare. In addition to that, AIM ImmunoTech is 2.36 times more volatile than Target Healthcare REIT. It trades about 0.0 of its total potential returns per unit of risk. Target Healthcare REIT is currently generating about 0.03 per unit of volatility. If you would invest  6,879  in Target Healthcare REIT on September 3, 2024 and sell it today you would earn a total of  1,521  from holding Target Healthcare REIT or generate 22.11% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.0%
ValuesDaily Returns

AIM ImmunoTech  vs.  Target Healthcare REIT

 Performance 
       Timeline  
AIM ImmunoTech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AIM ImmunoTech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Target Healthcare REIT 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Target Healthcare REIT are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Target Healthcare is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

AIM ImmunoTech and Target Healthcare Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AIM ImmunoTech and Target Healthcare

The main advantage of trading using opposite AIM ImmunoTech and Target Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AIM ImmunoTech position performs unexpectedly, Target Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Target Healthcare will offset losses from the drop in Target Healthcare's long position.
The idea behind AIM ImmunoTech and Target Healthcare REIT pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals